MAPK3 and neoplasm: Interestingly, a lower dose of farnesol was found to significantly inhibit the Ras-Raf-ERK1/2 signaling pathway, leading to the suppression of inflammatory gene expression, whereas a higher dose led to activation of the Ras-Raf-ERK1/2 signaling pathway in a skin tumorigenesis mouse model [18].